Trial Information
The National Lymphocare Study: An Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin's Lymphoma
Inclusion Criteria:
- Signed Informed Consent Form (unless the Institutional Review Board [IRB] has granted
a waiver of consent)
- Signed Authorization for the Use and Disclosure of Health Information document
- Age ≥18 years
- Histologic documentation of follicular NHL, according to Revised European-American
Lymphoma (REAL) classification system, as assessed by the local pathologist and
treating physician
- Initial diagnosis of follicular B-cell NHL within 6 months prior to enrollment
- Availability of cancer-specific historical data points in the patient's medical
records
Exclusion Criteria:
- Other indolent or histologic NHL subtypes
- Diagnosis of lymphoma > 6 months prior to enrollment
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Principal Investigator
Cinical Trials
Investigator Role:
Study Director
Investigator Affiliation:
Genentech
Authority:
United States: Institutional Review Board
Study ID:
U2963n
NCT ID:
NCT00097565
Start Date:
September 2004
Completion Date:
March 2014
Related Keywords:
- Lymphoma, Non Hodgkin
- Follicular Non-Hodgkin's Lymphoma
- Lymphoma
- Lymphoma, Follicular
- Lymphoma, Non-Hodgkin